Your browser is no longer supported. Please, upgrade your browser.
UBX Unity Biotechnology, Inc. daily Stock Chart
Unity Biotechnology, Inc.
Index- P/E- EPS (ttm)-6.61 Insider Own8.00% Shs Outstand44.48M Perf Week-27.27%
Market Cap711.68M Forward P/E- EPS next Y-2.03 Insider Trans- Shs Float37.94M Perf Month-2.56%
Income- PEG- EPS next Q-0.41 Inst Own30.40% Short Float5.64% Perf Quarter6.24%
Sales1.38M P/S514.96 EPS this Y-46.90% Inst Trans- Short Ratio15.40 Perf Half Y-
Book/sh7.42 P/B2.16 EPS next Y-3.60% ROA- Target Price27.25 Perf Year-
Cash/sh4.18 P/C3.83 EPS next 5Y- ROE- 52W Range12.75 - 24.56 Perf YTD-3.90%
Dividend- P/FCF- EPS past 5Y- ROI54.90% 52W High-34.85% Beta-
Dividend %- Quick Ratio19.90 Sales past 5Y- Gross Margin- 52W Low25.49% ATR1.79
Employees86 Current Ratio19.90 Sales Q/Q- Oper. Margin- RSI (14)41.98 Volatility14.37% 9.91%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume2.76 Prev Close16.82
ShortableYes LT Debt/Eq0.00 EarningsAug 09 AMC Payout- Avg Volume138.96K Price16.00
Recom2.00 SMA20-13.52% SMA50-3.85% SMA2001.94% Volume374,794 Change-4.88%
Sep-07-18Initiated Mizuho Buy
May-29-18Initiated Morgan Stanley Overweight $25
May-29-18Initiated Goldman Neutral $17
May-29-18Initiated Citigroup Buy $32
Sep-20-18 02:59PM  Do You Know Who Else Invests In Unity Biotechnology Inc (NASDAQ:UBX)? Simply Wall St.
Sep-17-18 08:00AM  Todays Research Reports on Stocks to Watch: Unity Biotechnology and Principia Biopharma ACCESSWIRE
Sep-14-18 09:53AM  Unity (UBX) Catches Eye: Stock Jumps 8.8% Zacks +10.00%
Sep-13-18 02:46PM  Unity Biotech CEO: We can 'absolutely' create drugs that slow, halt or reverse diseases of aging CNBC +8.81%
Sep-05-18 04:05PM  UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference GlobeNewswire
Aug-29-18 09:39AM  Why Jeff Bezos is backing this Silicon Valley scientist who is working on a cure for aging CNBC
Aug-09-18 04:05PM  UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-31-18 04:05PM  UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results GlobeNewswire
Jul-13-18 02:45PM  Here are Q2's 10 biggest VC-backed exits from the Bay Area American City Business Journals
Jun-25-18 08:00AM  UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee GlobeNewswire
Jun-13-18 04:00PM  UNITY Biotechnology, Inc. Added to Russell 3000®, 2000® and MicroCap® Indexes GlobeNewswire
07:20AM  Wired News Alexion Pharma and Complement Pharma Inked Deal to Co-develop Preclinical C6 Complement Inhibitor CP010 ACCESSWIRE
Jun-07-18 05:00PM  UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results GlobeNewswire
Jun-05-18 04:05PM  UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference GlobeNewswire
10:00AM  A Biotech Entrepreneur Aims To Help Us Stay Young While Growing Old Forbes
May-29-18 04:05PM  UNITY Biotechnology, Inc. to Announce First Quarter 2018 Financial Results GlobeNewswire
04:04PM  Unity Biotech Is A Buy On 'Novel Biology,' Morgan Stanley Says In Positive Initiation Benzinga
May-14-18 04:05PM  UNITY Biotechnology, Inc. Appoints Camille Landis as Senior Vice President of Corporate Development GlobeNewswire
10:32AM  3 New Healthcare Stocks to Buy Right Now InvestorPlace
May-07-18 04:05PM  UNITY Biotechnology, Inc. Announces Closing of Initial Public Offering GlobeNewswire
May-04-18 12:45AM  [$$] ARCH-backed Unity Bio Ends Lower in IPO The Wall Street Journal
May-03-18 04:37PM  Unity Biotech Shares Open For Trade Benzinga
May-02-18 07:10PM  UNITY Biotechnology, Inc. Announces Pricing of Initial Public Offering of Common Stock GlobeNewswire
12:45PM  [$$] Longevity Startups Come of Age The Wall Street Journal
Unity Biotechnology, Inc., a preclinical biotechnology company, engages in the research and development of therapeutics to extend human health span. The company's lead drug candidates include UBX0101 for musculoskeletal disease with an initial focus on osteoarthritis; and UBX1967 for ophthalmologic diseases. It is also developing programs in pulmonary disorders. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was founded in 2009 and is headquartered in Brisbane, California.